REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $620 | -77.8% | 6,819 | -90.7% | 0.00% | -71.4% |
Q4 2022 | $2,787 | -99.7% | 73,374 | +97.1% | 0.01% | +133.3% |
Q3 2022 | $935,000 | -76.3% | 37,218 | -4.9% | 0.00% | -62.5% |
Q3 2021 | $3,937,000 | -29.1% | 39,135 | -0.2% | 0.01% | -27.3% |
Q2 2021 | $5,549,000 | +8.2% | 39,210 | -23.7% | 0.01% | 0.0% |
Q1 2021 | $5,127,000 | -22.6% | 51,421 | -4.1% | 0.01% | -26.7% |
Q4 2020 | $6,627,000 | +393.4% | 53,613 | +288.8% | 0.02% | +275.0% |
Q3 2020 | $1,343,000 | -41.1% | 13,789 | -5.6% | 0.00% | -42.9% |
Q2 2020 | $2,279,000 | +8.1% | 14,607 | 0.0% | 0.01% | -12.5% |
Q1 2020 | $2,108,000 | – | 14,607 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |